Infliximab: all 244 studies that test it
Page 2 of 3. Open to participants first (30), then studies with results posted, then the rest; newest registration first within each.
- Infliximab and Adalimumab in Inflammatory Bowel Disease Patients.CompletedNCT05291039Not applicable
- REduCed Dose of TNFi in Patients With Ankylosing SpondyliTis (RECAST)Status unknownNCT05164198Phase 4
- Management of Moderate POstoperative Recurrence in Crohn's Disease: a randoMizEd contROLled Trial of Therapeutic Escalation, the POMEROL Trial. (POMEROL)Status unknownNCT05072782Phase 4
- PD-1 Antibody Therapy + Infliximab for Metastatic MelanomaActive, not recruitingNCT05034536Phase 2
- Model-informed Dose De-escalation of Infliximab in Patients With Inflammatory Bowel DiseasesCompletedNCT04982172Phase 4
- Infliximab in the Treatment of Patients With Severe COVID-19 DiseaseCompletedNCT04922827Phase 2
- Intravitreal Infliximab for Proliferative VitreoretinopathyCompletedNCT04891991Phase 2
- Proactive Infliximab Optimization Using a Pharmacokinetic Dashboard Versus Standard of Care in Patients With Inflammatory Bowel Disease: The OPTIMIZE TrialActive, not recruitingNCT04835506Phase 4
- The Study of Infliximab (CMAB008 and Remicade) in Healthy Subjects to Compare the PK and SafetyCompletedNCT04779892Phase 1
- Multicentre, Randomized, Prospective Trial Evaluating the Efficacy and Safety of Infliximab to Tocilizumab in Refractory or Relapsing Takayasu ArteritisStatus unknownNCT04564001Phase 2
- Efficacy of Immunoglobulin Plus Infliximab for the Early Regression of Coronary Artery Lesion in Kawasaki DiseaseWithdrawnNCT04535518Phase 3
- Treatments for COVID-19: Canadian Arm of the SOLIDARITY TrialStatus unknownNCT04330690Phase 3
- Infliximab for Treatment of Immune Checkpoint Inhibitor ColitisActive, not recruitingNCT04305145Phase 2
- A Clinical Trial of Infliximab for Childhood UveitisStatus unknownNCT04150770Phase 4
- TITRATE (inducTIon for AcuTe UlceRATivE Colitis)TerminatedNCT03937609Phase 4
- Efficacy of Remission-induction Regimen With Infliximab for Severe Extrathoracic Sarcoidosis (EFIRTES)CompletedNCT03704610Phase 3
- EFFICACI : EFFicacy of Intravenous Infliximab Versus Vedolizumab After Failure of subCutaneous Anti-TNF in Patients With UlCerative ColitisCompletedNCT03679546Phase 4
- CMAB008 With MTX Therapy in Adult Patients With Moderately to Severely Active Rheumatoid ArthritisCompletedNCT03478111Phase 3
- Induction Therapy With Anti-TNFα vs Cyclophosphamide in Severe Behçet DiseaseCompletedNCT03371095Phase 3
- Infliximab Accelerated Induction in Moderate to Severe Pediatric UCTerminatedNCT03209232Not applicable
- Cyclophosphamide vs. Infliximab for Refractory Idiopathic Scleritis (CIRIS)WithdrawnNCT03088293Phase 3
- GIS-SUSANTI-TNF-2015 (Anti-TNF Discontinuation )CompletedNCT02994836Phase 4
- Topical Infliximab for Sterile Corneal MeltCompletedNCT02987686Phase 1
- Predictability Studies on the Efficacy of TNF-α Inhibitors in Chinese RA From "Real World"Status unknownNCT02878161Phase 4
- Optimization of Infliximab Withdrawal Strategy for Rheumatoid ArthritisCompletedNCT02770794Phase 4
- Optimising Infliximab Induction Therapy for Acute Severe Ulcerative ColitisCompletedNCT02770040Phase 4
- An Investigational Study of Infliximab With Prednisone or Methylprednisolone Versus Prednisone Combination Treatment in Immune Related or Severe Diarrhea in Patients Treated With Yervoy and/or OpdivoWithdrawnNCT02763761Phase 2
- Comparative Clinical Trial of Efficacy and Safety of BCD-055 and Remicade® in Combination With Methotrexate in Patients With Active Rheumatoid ArthritisCompletedNCT02762838Phase 3
- Comparative Clinical Trial to Evaluate Efficacy and Safety of BCD-055 and Remicade® in Patients With Ankylosing SpondylitisCompletedNCT02762812Phase 3
- Effects of the TNF-alpha Inhibiton on Hemodynamic Parameters in Resistant HypertensionCompletedNCT02743390Phase 4
- Clinical and Molecular Phenotyping in IBDCompletedNCT02694588Not applicable
- BOW015 (Infliximab-EPIRUS) and Infliximab in Patients With Active Rheumatoid Arthritis: The UNIFORM StudyStatus unknownNCT02683564Phase 3
- Intravitreal Infliximab in Refractory Uveitis in Behcet's Disease: A Safety and Efficacy Clinical StudyCompletedNCT02620618Phase 1/2
- TOPIT; Trough Level Optimized Pediatric Inflammatory Bowel Disease Therapy: A Multicenter Study Comparing Effectiveness of Trough Level Optimized Infliximab Maintenance Therapy With Standard Dosing Regimen of Pediatric Patients With Crohn's DiseaseStatus unknownNCT02522169Not applicable
- Top-down Infliximab Study in Kids With Crohn's DiseaseCompletedNCT02517684Phase 4
- A Study to Evaluate Efficacy and Safety of Infliximab in Participant With Moderate-to-Severe Refractory Intestinal Behcet's DiseaseCompletedNCT02505568Phase 3
- Clinical Study of Anti-tumor Necrosis Factor Therapy in Patients With Takayasu ArteritisStatus unknownNCT02457585Phase 2
- A Randomized, Multicenter Open Label Study Comparing Early Administration of Azathioprine Plus IFX to Steroids Plus Azathioprine for Acute Severe ColitisCompletedNCT02425852Phase 4
- Infliximab for Kawasaki Disease Patients Resistant to IVIG : a Multicentre, Prospective, Randomised TrialCompletedNCT02298062Phase 3
- Anti-TNFα Use During Elective Foot and Ankle Surgery in Patients With Rheumatoid ArthritisStatus unknownNCT02242474Phase 4
- A proSpective Randomized Controlled Trial comParing infliximAb-antimetabolites Combination Therapy to Anti-metabolites monotheRapy and Infliximab monothErapy in Crohn's Disease Patients in Sustained Steroid-free Remission on Combination TherapyCompletedNCT02177071Phase 4
- The NOR-SWITCH StudyCompletedNCT02148640Phase 4
- Effects of Biological Treatment on Blood Pressure and Endothelial Function in Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing SpondylitisStatus unknownNCT02132234Phase 4
- Topical Infliximab in Autoimmune Eyes With KeratoprosthesisWithdrawnNCT02126020Phase 1/2
- Early Serum Infliximab Levels in Severe Ulcerative Colitis.CompletedNCT01971814Phase 1
- Pharmacokinetics Study of NI-071CompletedNCT01931189Phase 1
- A Phase 3 Study of NI-071 in Patients With Rheumatoid ArthritisCompletedNCT01927263Phase 3
- Infliximab and Classic DMARDs in the Rheumatoid Arthritis PatientsStatus unknownNCT01915537Not applicable
- Infliximab Top-down in Pediatric CrohnTerminatedNCT01880307Phase 4
- A Pharmacokinetics Study Comparing PF-06438179 and Infliximab in Healthy Volunteers (REFLECTIONS B537-01)CompletedNCT01844804Phase 1
- Discontinuation of Infliximab Therapy in Patients With Crohn's Disease During Sustained Complete RemissionCompletedNCT01817426Phase 4
- Stopping TNF Alpha Inhibitors in Rheumatoid ArthritisActive, not recruitingNCT01793519Phase 4
- Efficacy and Safety of Top-down Therapy in Pediatric Crohn's DiseaseWithdrawnNCT01752790Phase 4
- Expression of TIM-3 and Correlation With Disease Activity in Pediatric Crohn's Disease With Anti TNF-α TherapyCompletedNCT01661257Phase 3
- TNF-alfa Inhibitors and Antibody Production in Patients With PsoriasisStatus unknownNCT01657513Not applicable
- A Randomized, Multi-Center Biomarker Trial to Predict Therapeutic Responses of Patients With Rheumatoid Arthritis to a Specific Biologic Mode of ActionCompletedNCT01638715Phase 4
- An Extension Study to Demonstrate Long-Term Efficacy and Safety of CT-P13 When Co-administered With Methotrexate in Patient With Rheumatoid Arthritis Who Were Treated With Infliximab (Remicade or CT-P13) in Study CT-P13 3.1CompletedNCT01571219Phase 3
- An Extension Study to Demonstrate the Equivalence of Long-Term Efficacy and Safety of CT-P13 in Patients With Ankylosing Spondylitis Who Were Treated With Infliximab (Remicade or CT-P13) in Study CT-P13 1.1CompletedNCT01571206Phase 1
- Study of NI-071 in Comparison With Remicade in Patients With Rheumatoid ArthritisCompletedNCT01567358Phase 1
- Efficacy and Safety of Two Regimens of Maintenance Therapy in Children With Crohn DiseaseStatus unknownNCT01559142Phase 3
- A Study to Evaluate the Effectiveness and Safety of Infliximab in Chinese Patients With Active Ulcerative ColitisCompletedNCT01551290Phase 3
- Study Investigating Tailored Treatment With Infliximab for Active Crohn's DiseaseCompletedNCT01442025Phase 4
- Infliximab Therapy in Patients With Refractory Polymyalgia RheumaticaStatus unknownNCT01423591Phase 3
- Evaluation of Histologic and Endoscopic Remission Induced by Infliximab in Moderate to Severe Ulcerative ColitisCompletedNCT01408810Phase 4
- Infliximab as Induction Therapy in Early Rheumatoid Arthritis (IDEA)CompletedNCT01308255Phase 4
- SWITCH Clinical Trial for Patients With Rheumatoid Arthritis Who Have Failed an Initial TNF-blocking Drug.CompletedNCT01295151Phase 4
- Ultrasonographic Monitoring of Response to Infliximab in Patients With Rheumatoid ArthritisStatus unknownNCT01282528Phase 4
- Infliximab, Regulatory T Cells, IL2 and Crohn's DiseaseWithdrawnNCT01266785Not applicable
- Infliximab to Improve Retention of the Boston Keratoprosthesis in Patients After Stevens Johnson Syndrome/ Toxic Epidermal Necrolysis (SJS/TENS)WithdrawnNCT01256489Phase 1/2
- A 6-Months Infliximab Or Placebo Study In UA At High Risk Of RA:Clinical,Radiological And Synovial BenefitCompletedNCT01245361Not applicable
- Evaluation of Lymphocytic Infiltrate, Dendritic Cells and Cytokines Expression in Psoriatic Lesion and Normal Skin Before and After TNF Alfa Inhibitors TherapyStatus unknownNCT01237262Phase 4
- Program evaLuating the Autoimmune Disease iNvEstigational Drug cT-p13 in AS Patients(PLANETAS)CompletedNCT01220518Phase 1
- Program evaLuating the Autoimmune Disease iNvEstigational Drug cT-p13 in RA Patients(PLANETRA)CompletedNCT01217086Phase 3
- The Efficacy of Open Label Infliximab for the Induction and Maintenance of Mucosal Healing in Small Bowel Crohn's Disease Assessed Through Wireless Camera EndoscopyCompletedNCT01181765Phase 4
- Effectiveness and Safety of Early Treatment With Infliximab for Hip Arthritis Associated With Ankylosing Spondylitis (AS) (P06451)WithdrawnNCT01148901Phase 4
- Aggressive Combination Drug Therapy in Very Early Polyarticular Juvenile Idiopathic ArthritisCompletedNCT01015547Phase 3
- Rotation or Change of Biotherapy After First Anti-TNF Treatment Failure for Rheumatoid ArthritisCompletedNCT01000441Phase 4
- Pilot Study for the Evaluation of Intravitreal Infliximab in the Treatment of Diabetic Macular EdemaStatus unknownNCT00959725Phase 1/2
- Pilot Study for the Evaluation of Intravitreal Infliximab in the Treatment of Uveitic Macular EdemaWithdrawnNCT00958906Phase 1/2
- Efficacy and Safety Study of Infliximab (Remicade) to Treat Early Ankylosing SpondylitisCompletedNCT00936143Phase 4
- TNF-blocking Therapy in Combination With Disease-modifying Antirheumatic Drugs in Early Rheumatoid ArthritisStatus unknownNCT00908089Phase 4
- The Chinese University of Hong Kong Early Arthritis StudyCompletedNCT00901550Not applicable
- The HAM Infliximab StudyTerminatedNCT00823641Phase 2
- Efficacy of Infliximab in the Treatment of Patients Affected by Corticodependent Crohn's Disease (P02732)TerminatedNCT00796250Phase 3
- Study to Assess the Safety and Efficacy of Infliximab to Treat Hidradenitis SuppurtativaCompletedNCT00795574Phase 2
- Efficacy of Remicade in the Treatment of Active Rheumatoid Arthritis Despite Methotrexate (Study P03027)CompletedNCT00794898Phase 4
- Growth Factor Concentration to Predict an Ankylosing Spondylitis Patient's Response to Infliximab (Study P04041)(COMPLETED)CompletedNCT00779935Phase 4
- A Study of the Efficacy and Tolerance of Remicade in the Treatment of Active Ankylosing Spondylitis (Study P04042)(COMPLETED)CompletedNCT00779012Phase 4
- Anti-Cytokine Therapy for VasculitisCompletedNCT00753103Phase 2
- Effects of Infliximab on Insulin Sensitivity and Beta Cell Function in Insulin Resistant Human ObesityCompletedNCT00636142Phase 4
- Efficacy, Safety, and Tolerability Study of Infliximab in Juvenile SpondyloarthropathiesCompletedNCT00591201Phase 2/3
- Anti Cytokine Combination Therapy With Daclizumab and Infliximab for Treatment of Steroid Refractory Acute GVHDCompletedNCT00574470Phase 4
- Stop Infliximab in Patients With Crohn's DiseaseCompletedNCT00571337Phase 3
- Top Down Versus Step Up Strategies in Crohn's DiseaseCompletedNCT00554710Phase 4
- Off Label Use of Infliximab in Adult Patients With Severe Eosinophilic EsophagitisCompletedNCT00523354Phase 2
- Intraarticular Injection of InfliximabWithdrawnNCT00521963Phase 2/3
- Medical Treatment of Colitis in Patients With Hermansky-Pudlak SyndromeWithdrawnNCT00514982Phase 2
- Infliximab and Methotrexate in Ankylosing SpondylitisCompletedNCT00507403Phase 4
- Treatment of Refractory Diabetic Macular Edema With InfliximabTerminatedNCT00505947Phase 3
- Treatment With TNF Blockade, Infliximab, in Patients With MyositisCompletedNCT00443222Phase 2/3